首页 >
法规速递
-
关于公开征求ICH《M7（R2）：评估和控制药物中DNA反应性（致突变）杂质以限制潜在致癌风险》指导原则正文、问答及附录实施建议和中文版意见的通知-2023/8/25
2023-08-25查看详情 > -
国家药监局药审中心关于发布《生长激素制剂用于生长激素缺乏症临床试验技术指导原则》的通告（2024年第18号）-2024/3/1
2024-03-12查看详情 > -
Page: Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) meetings-2025/2/5
2025-02-06查看详情 > -
Document: Final European Union herbal monograph on Urtica dioica L.; Urtica urens L., radix - Revision 1-2025/3/12
2025-03-13查看详情 > -
Document: Quality Review of Documents (QRD) annotated template v11: From for submission of comments to public consultation-2025/4/14
2025-04-15查看详情 > -
Document: Start of procedure - extension of marketing authorisation (26 April - 22 May 2025)-2025/5/27
2025-05-28查看详情 > -
Page: Guidance on the application of the revised variations framework-2025/6/30
2025-07-01查看详情 > -
CVM GFI #294 - Animal Food Ingredient Consultation (AFIC)-2025/7/31
2025-08-04查看详情 > -
Document: MedDRA important medical event terms list - version 28.1-2025/9/23
2025-09-24查看详情 > -
Page: Plasma master file certificates-2025/10/28
2025-10-29查看详情 >
